La vendita allo scoperto per eHealth dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di eHealth. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

eHealth (NASDAQ:EHTH) Azioni, Report sulle vendite allo scoperto

eHealth

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

eHealth Inc

RBC Capital analyst Frank Morgan maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Sector Perform and lowers the price target from $13 to $11.

News

Price Target

Analyst Ratings

EHTH

RBC Capital Maintains Sector Perform on eHealth, Lowers Price Target to $11

Craig-Hallum analyst George Sutton upgrades eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) from Hold to Buy and raises the price target from $5 to $7.

Upgrades

Craig-Hallum Upgrades eHealth to Buy, Raises Price Target to $7

WIIM

EHealth shares are trading lower after the company reported worse-than-expected Q3 financial results.

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.28) by 14.84 percent. The company reported quarterly sales of $58.409 million which missed the analyst consensus estimate of $58.557 million by 0.25 percent. This is a 9.75 percent decrease over sales of $64.718 million the same period last year.

Earnings

Earnings Misses

eHealth Q3 2024 Adj. EPS $(1.47) Misses $(1.28) Estimate, Sales $58.409M Miss $58.557M Estimate

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) affirms FY2024 sales outlook from $470.00 million-495.00 million to $470.00 million-495.00 million.

Guidance

eHealth Affirms FY2024 Sales Guidance to $470.00M-495.00M  VS Est. 483.54M

eHealth Secures HITRUST i1 Certification For Carrier Integration Platform, Reinforcing Commitment To Data Protection And Cybersecurity In Healthcare

CLOV

ELEV

GOCO

Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs For Common Conditions With Periodic Updates Based On New Generics, Clinical Indications, And Pricing Trends

Deutsche Bank analyst George Hill maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Hold and lowers the price target from $5 to $2.

Deutsche Bank Maintains Hold on eHealth, Lowers Price Target to $2

Craig-Hallum analyst George Sutton maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Hold and lowers the price target from $6 to $5.

Craig-Hallum Maintains Hold on eHealth, Lowers Price Target to $5

eHealth shares are trading lower, reversing after earlier rising on better-than-expected Q2 financial results.

General

eHealth shares are trading higher after the company reported better-than-expected Q2 sales results and issued FY24 revenue guidance above estimates.

eHealth Sees FY24 Revenue $470M-$495M Vs $466.574M Est.

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(1.14) by 16.67 percent. The company reported quarterly sales of $65.856 million which beat the analyst consensus estimate of $55.024 million by 19.69 percent. This is a 1.37 percent decrease over sales of $66.768 million the same period last year.

Earnings Beats

eHealth Q2 2024 GAAP EPS $(1.33) Misses $(1.14) Estimate, Sales $65.856M Beat $55.024M Estimate

Management

eHealth CEO Fran Soistman To Retire In Early 2025, Co. Commences Search For Successor

Today&nbsp;eHealth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) (eHealth.com), a leading online private health insurance marketplace, applauded the decision by the Centers for Medicare and Medicaid Services (CMS) to temporarily retain CY2024 agent compensation rates for CY2025. CMS's decision comes in response to preliminary injunctions issued by the US District Court for the Northern District of Texas in the case of Americans for Beneficiary Choice v. HHS.

eHealth Applauds Decision By CMS To Retain 2024 Medicare Compensation Guidelines For 2025

<a href="https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/" title="https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/">https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/</a>

'House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests' - Stat News

John Dolan, eHealth&#39;s chief accounting officer will be appointed SVP, CFO on&nbsp;August 31, 2024. In connection with his role as SVP, CFO, Mr. Dolan will also serve as the company&#39;s principal financial and accounting officer.&nbsp;

eHealth CFO John Stelben To Retire At The End Of August 2024; Chief Accounting Officer John Dolan To Be Named CFO

eHealth shares are trading higher after the company reported better-than-expected Q1 sales results and issued FY24 revenue guidance.

eHealth (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ehth#NASDAQ">EHTH</a>) reported quarterly losses of $(0.96) per share which missed the analyst consensus estimate of $(0.71) by 35.21 percent. The company reported quarterly sales of $92.967 million which beat the analyst consensus estimate of $80.610 million by 15.33 percent. This is a 26.10 percent increase over sales of $73.723 million the same period last year.

Penny Stocks

eHealth Q1 2024 GAAP EPS $(0.96) Misses $(0.71) Estimate, Sales $92.967M Beat $80.610M Estimate

eHealth Sees FY24 Revenue $450M-$475M Vs $461.68M Est.

Craig-Hallum analyst George Sutton maintained a Hold rating on Ehealth (EHTH – Research Report) today. The company's shares closed yesterday at $3....

Ehealth (EHTH) Receives a Hold from Craig-Hallum

Ehealth ( ($EHTH) ) has shared an announcement. eHealth, Inc. has expanded its Board of Directors with the appointment of Prama Bhatt as a Class II...

eHealth Enhances Board with Strategic Digital Expertise

Ehealth ( ($EHTH) ) has issued an announcement. eHealth, Inc. has launched a retention incentive program for three executive officers, offering cas...

eHealth Announces Executive Retention Incentives Post-CEO Departure

In a report released today, George Sutton from Craig-Hallum maintained a Buy rating on Ehealth (EHTH – Research Report). The company's shares close...

Ehealth (EHTH) Gets a Buy from Craig-Hallum

eHealth (EHTH) has successfully achieved Hitrust i1 certification for its carrier integration platform hosted through Amazon (AMZN) Web Services. H...

eHealth receives Hitrust i1 certification for managing data protectione

Here's the major earnings before the open tomorrow

eHealth GAAP EPS of -$1.83 misses by $0.31, revenue of $58.41M misses by $0.45M

Craig-Hallum analyst George Sutton upgraded eHealth (EHTH) to Buy from Hold with a price target of $7, up from $5. Results were largely in line wit...

Craig-Hallum says eHealth 'beginning to hit its stride,' upgrades to Buy

Craig-Hallum upgraded eHealth (EHTH) to Buy from Hold with a price target of $7, up from $5. Published first on TheFly – the ultimate source for re...

eHealth upgraded to Buy from Hold at Craig-Hallum

Craig-Hallum analyst George Sutton maintained a Buy rating on Ehealth (EHTH – Research Report) today. The company's shares closed yesterday at $5.1...

Craig-Hallum Sticks to Its Buy Rating for Ehealth (EHTH)

ABUS

ADRNY

AMZN

ATHM

AUDC

BMWYY

CELH

CLBT

CNDT

ENOV

FOLD

HENKY

IONS

LNTH

MCFT

MKTX

MOGO

NEON

OESX

PERI

PFGC

PRGO

RPRX

SLQT

SNDR

STWD

TCPC

TEVA

TRMB

URGN

VONOY

VRNOF

Press Releases

eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

eHealth Earns Great Place to Work® Certification, Recognizing Outstanding Workplace Culture

eHealth, Inc. to Hold Third Quarter 2024 Earnings Call on November 6 at 8:30 a.m. Eastern Time

eHealth Achieves HITRUST i1 Certification for Managing Data Protection and Mitigating Cybersecurity Threats

eHealth, Inc. to Participate in the UBS Global Healthcare Conference

Enrollees Give Affordable Care Act Mixed Reviews Ahead of Open Enrollment and November Election

eHealth, Inc. Announces Third Quarter 2024 Results

eHealth, Inc. Presenting at the UBS Global Healthcare Conference

eHealth Wins 2024 Healthcare Marketing Impact Award from Modern Healthcare & Ad Age

Facing Increased Costs, 64% of Medicare Beneficiaries Express Higher Confidence in the Future of Medicare Under a Trump Administration

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

eHealth

Vendite allo scoperto

eHealth (NASDAQ:EHTH) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO